Skip to main content
Top
Published in: Familial Cancer 3/2014

01-09-2014 | Original Article

How harmful is genetic testing for familial adenomatous polyposis (FAP) in young children; the parents’ experience

Authors: Anna A. Kattentidt-Mouravieva, M. den Heijer, I. van Kessel, A. Wagner

Published in: Familial Cancer | Issue 3/2014

Login to get access

Abstract

Predictive genetic testing for familial adenomatous polyposis (FAP) is routinely offered to children at-risk from the age of 10 years onwards. Predictive testing for FAP at a younger age is debatable, because of absence of medical benefits. However, circumstances may arise when testing at a younger age (<10 years) is appropriate. Currently, there is a lack of published experience with predictive testing of children at this young age. We evaluated 13 children who were tested for FAP at the age younger than 10 years; 7 mutation-carriers and 6 non-carriers. Parents of these children were re-contacted and open-ended semi-structured interviewed. None of the contacted parents regretted the timing of genetic testing. The major reasons for testing at the young age were (1) testing of all children in the family at the same moment; (2) certainty for the future; and (3) preparing the child for future surveillance. None of the parents observed changes in mental or physical health in their child after testing. Also, young genetic testing did not lead to colon surveillance before it was indicated. Genetic testing for FAP at a young age is experienced as causing no harm by parents. Future studies should evaluate children’s own experiences with early genetic testing.
Literature
1.
go back to reference Croner RS, Brueckl WM, Reingruber B, Hohenberger W, Guenther K (2005) Age and manifestation related symptoms in familial adenomatous polyposis. BMC Cancer 5:24PubMedCrossRefPubMedCentral Croner RS, Brueckl WM, Reingruber B, Hohenberger W, Guenther K (2005) Age and manifestation related symptoms in familial adenomatous polyposis. BMC Cancer 5:24PubMedCrossRefPubMedCentral
2.
go back to reference Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K (2006) Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 70(5):374–381PubMedCrossRef Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K (2006) Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clin Genet 70(5):374–381PubMedCrossRef
3.
go back to reference Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K (2009) Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations. Eur J Hum Genet 17(6):711–719PubMedCrossRefPubMedCentral Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K (2009) Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations. Eur J Hum Genet 17(6):711–719PubMedCrossRefPubMedCentral
4.
go back to reference Crawford G, Lucassen A (2010) Predictive genetic testing in a young child: a case report. Fam Cancer 9(1):61–64PubMedCrossRef Crawford G, Lucassen A (2010) Predictive genetic testing in a young child: a case report. Fam Cancer 9(1):61–64PubMedCrossRef
5.
go back to reference Wertz DC, Fanos JH, Reilly PR (1994) Genetic testing for children and adolescents. Who decides? J Am Med Assoc 272(11):875–881CrossRef Wertz DC, Fanos JH, Reilly PR (1994) Genetic testing for children and adolescents. Who decides? J Am Med Assoc 272(11):875–881CrossRef
6.
go back to reference Fanos JH (1997) Developmental tasks of childhood and adolescence: implications for genetic testing. Am J Med Genet 71(1):22–28PubMedCrossRef Fanos JH (1997) Developmental tasks of childhood and adolescence: implications for genetic testing. Am J Med Genet 71(1):22–28PubMedCrossRef
8.
go back to reference Davis DS (1997) Genetic dilemmas and the child’s right to an open future. Hastings Center Report 27(2):7–15PubMedCrossRef Davis DS (1997) Genetic dilemmas and the child’s right to an open future. Hastings Center Report 27(2):7–15PubMedCrossRef
9.
10.
go back to reference Douma KF, Aaronson NK, Vasen HF, Bleiker EM (2008) Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psycho-oncology 17(8):737–745PubMedCrossRef Douma KF, Aaronson NK, Vasen HF, Bleiker EM (2008) Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psycho-oncology 17(8):737–745PubMedCrossRef
11.
go back to reference Holland J (1997) Should parents be permitted to authorize genetic testing for their children? Fam Law Q 31(2):321–353PubMed Holland J (1997) Should parents be permitted to authorize genetic testing for their children? Fam Law Q 31(2):321–353PubMed
12.
go back to reference Ross LF, Moon MR (2000) Ethical issues in genetic testing of children. Arch Pediatr Adolesc Med 154(9):873–879PubMedCrossRef Ross LF, Moon MR (2000) Ethical issues in genetic testing of children. Arch Pediatr Adolesc Med 154(9):873–879PubMedCrossRef
13.
go back to reference Lessick M, Faux S (1998) Implications of genetic testing of children and adolescents. Holist Nurs Pract 12(3):38–46PubMedCrossRef Lessick M, Faux S (1998) Implications of genetic testing of children and adolescents. Holist Nurs Pract 12(3):38–46PubMedCrossRef
14.
go back to reference Gjone H, Diseth TH, Fausa O, Novik TS, Heiberg A (2011) Familial adenomatous polyposis: mental health, psychosocial functioning and reactions to genetic risk in adolescents. Clin Genet 79(1):35–43PubMedCrossRef Gjone H, Diseth TH, Fausa O, Novik TS, Heiberg A (2011) Familial adenomatous polyposis: mental health, psychosocial functioning and reactions to genetic risk in adolescents. Clin Genet 79(1):35–43PubMedCrossRef
15.
go back to reference Codori AM, Petersen GM, Boyd PA, Brandt J, Giardiello FM (1996) Genetic testing for cancer in children. Short-term psychological effect. Arch Pediatr Adolesc Med 150(11):1131–1138PubMedCrossRef Codori AM, Petersen GM, Boyd PA, Brandt J, Giardiello FM (1996) Genetic testing for cancer in children. Short-term psychological effect. Arch Pediatr Adolesc Med 150(11):1131–1138PubMedCrossRef
16.
go back to reference Kattentidt-Mouravieva AA, Escher JC, Kessel Iv, Beishuizen A, Vanheusden K, Wagner A (2010) Familiaire adenomateuze polyposis coli op de kinderleeftijd. Tijdschr Kindergeneeskd 78(1):28–33CrossRef Kattentidt-Mouravieva AA, Escher JC, Kessel Iv, Beishuizen A, Vanheusden K, Wagner A (2010) Familiaire adenomateuze polyposis coli op de kinderleeftijd. Tijdschr Kindergeneeskd 78(1):28–33CrossRef
17.
go back to reference The British Society for Human Genetics (2010) Report on the Genetic Testing of Children 2010, British Society for Human Genetics The British Society for Human Genetics (2010) Report on the Genetic Testing of Children 2010, British Society for Human Genetics
19.
go back to reference Kodish ED (1999) Testing children for cancer genes: the rule of earliest onset. J Pediatr 135(3):390–395PubMedCrossRef Kodish ED (1999) Testing children for cancer genes: the rule of earliest onset. J Pediatr 135(3):390–395PubMedCrossRef
20.
go back to reference Michie S, McDonald V, Bobrow M, McKeown C, Marteau T (1996) Parents’ responses to predictive genetic testing in their children: report of a single case study. J Med Genet 33(4):313–318PubMedCrossRefPubMedCentral Michie S, McDonald V, Bobrow M, McKeown C, Marteau T (1996) Parents’ responses to predictive genetic testing in their children: report of a single case study. J Med Genet 33(4):313–318PubMedCrossRefPubMedCentral
21.
go back to reference Plass AM, Baars MJ, Cornel MC et al (2009) Testing the children: do non-genetic health-care providers differ in their decision to advise genetic presymptomatic testing on minors? A cross-sectional study in five countries in the European Union. Genet Test Mol Biomark 13(3):367–376CrossRef Plass AM, Baars MJ, Cornel MC et al (2009) Testing the children: do non-genetic health-care providers differ in their decision to advise genetic presymptomatic testing on minors? A cross-sectional study in five countries in the European Union. Genet Test Mol Biomark 13(3):367–376CrossRef
22.
go back to reference Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB (2010) The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer 9(1):27–35PubMedCrossRef Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB (2010) The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer 9(1):27–35PubMedCrossRef
23.
go back to reference Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB (2008) “You’re one of us now”: young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet 148C(1):47–55PubMedCrossRef Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB (2008) “You’re one of us now”: young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet 148C(1):47–55PubMedCrossRef
24.
go back to reference Robertson SSJ (2001) Is there a case in favour of predictive genetic testing in young children? Bioethics 15(1):26–49PubMedCrossRef Robertson SSJ (2001) Is there a case in favour of predictive genetic testing in young children? Bioethics 15(1):26–49PubMedCrossRef
25.
go back to reference Codori AM, Zawacki KL, Petersen GM et al (2003) Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A 116A(2):117–128PubMedCrossRef Codori AM, Zawacki KL, Petersen GM et al (2003) Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A 116A(2):117–128PubMedCrossRef
26.
go back to reference Duncan RE, Delatycki MB (2006) Predictive genetic testing in young people for adult-onset conditions: where is the empirical evidence? Clin Genet 69(1):8–16; discussion 7–20 Duncan RE, Delatycki MB (2006) Predictive genetic testing in young people for adult-onset conditions: where is the empirical evidence? Clin Genet 69(1):8–16; discussion 7–20
28.
go back to reference Committee on Bioethics, Committee on Genetics, The American College of Medical Genetics and Genomics Social, Ethical, and Legal Issues Committee (2013) POLICY STATEMENT: Ethical and policy issues in genetic testing and screening of children. Pediatrics 131(3):620–622 Committee on Bioethics, Committee on Genetics, The American College of Medical Genetics and Genomics Social, Ethical, and Legal Issues Committee (2013) POLICY STATEMENT: Ethical and policy issues in genetic testing and screening of children. Pediatrics 131(3):620–622
29.
go back to reference Levine FR, Coxworth JE, Stevenson DA, Tuohy T, Burt RW, Kinney AY (2010) Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors. J Genet Couns 19(3):269–279PubMedCrossRefPubMedCentral Levine FR, Coxworth JE, Stevenson DA, Tuohy T, Burt RW, Kinney AY (2010) Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors. J Genet Couns 19(3):269–279PubMedCrossRefPubMedCentral
Metadata
Title
How harmful is genetic testing for familial adenomatous polyposis (FAP) in young children; the parents’ experience
Authors
Anna A. Kattentidt-Mouravieva
M. den Heijer
I. van Kessel
A. Wagner
Publication date
01-09-2014
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 3/2014
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-014-9724-5

Other articles of this Issue 3/2014

Familial Cancer 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine